Zhejiang Silk Road Fund logo

Zhejiang Silk Road Fund

Asia, Zhejiang, China, Hangzhou

Description

Zhejiang Silk Road Fund is an affiliated private equity fund of Zhejiang United Investment Group.

Investor Profile

Zhejiang Silk Road Fund has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (67%)
  • Series Unknown (33%)

Country Focus

  • China (67%)
  • France (33%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Robotics
  • Cloud Computing
  • Enterprise Software
  • Information Technology
  • Saas
  • Software
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zhejiang Silk Road Fund frequently co-invest with?

Tusholdings
Asia, Beijing, China, Beijing
Co-Investments: 1
Huatai Securities
Asia, Jiangsu, China, Nanjing
Co-Investments: 1
Dragoneer Investment Group
North America, California, United States, San Francisco
Co-Investments: 1
Anaxago
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
MSA Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Huaye Tiancheng Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
MS
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Zhejiang Silk Road Fund?

Shenqi Medical

Shanghai, Shanghai, China

Shenqi Medical focuses on the research and manufacture of innovative medical devices.

Health CareManufacturingMedical Device
Series UnknownJan 4, 2022
Xforceplus

Shanghai, Shanghai, China

Xforceplus develops enterprise collaborative solutions for software as a service.

Cloud ComputingEnterprise SoftwareInformation TechnologySaaSSoftware
Series CJun 1, 2021
Amount Raised: $100,000,000
Robocath

Rouen, Haute-Normandie, France

Robocath is a medical robotics startup that partners with healthcare professionals to develop robotic solutions for vascular disease.

BiotechnologyHealth CareMedicalRobotics
Series CApr 29, 2020
Amount Raised: $43,509,853